Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MLYCD | O95822 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL28296789 | 0.82 | ALDH1A1 (0.35) | MLYCDCA2ALDH1A1TP53TSHR | |
| Trifluoroacetic Acid SCHEMBL357774 | 0.81 | TP53 (0.36) | MLYCDCA2ALDH1A1TP53TSHR | |
| Trifluoroacetic Acid SCHEMBL3140803 | 0.79 | TP53 (0.44) | CA2ALDH1A1TP53TSHRL3MBTL1 | |
| Trifluoroacetic Acid SCHEMBL27714775 | 0.79 | TP53 (0.44) | CA2ALDH1A1TP53TSHRL3MBTL1 | |
| Bicarbonate SCHEMBL8871100 | 0.78 | TDP1 (0.61) | TDP1CA2ALDH1A1TP53TSHR | |
| Trifluoroacetic Acid SCHEMBL29019090 | 0.78 | TP53 (0.38) | MLYCDCA2ALDH1A1TP53TSHR | |
| Trifluoroacetic Acid SCHEMBL3055318 | 0.77 | ALDH1A1 (0.38) | MLYCDCA2ALDH1A1TP53TSHR | |
| Trifluoroacetic Acid SCHEMBL7793452 | 0.77 | TP53 (0.42) | MLYCDCA2ALDH1A1TP53TSHR | |
| Trifluoroacetic Acid SCHEMBL5493316 | 0.77 | RNPEP (0.36) | TDP1MLYCDCA2ALDH1A1TP53 | |
| Trifluoroacetic Acid SCHEMBL20854191 | 0.77 | ALDH1A1 (0.35) | MLYCDCA2ALDH1A1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350150-A | 4-Butoxyphenyl propenone and preparation method and application thereof | 北京茗泽中和药物研究有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-114805289-B | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2024-05-28 | — | — | CN | claimed |
| US-11851392-B2 | Self-condensation of aldehydes | EASTMAN CHEMICAL COMPANY (US) | 2023-12-26 | — | — | US | claimed |
| CN-115974664-A | Synthesis method of 5-chloro-1-indanone | 合肥工业大学 | 2023-04-18 | — | — | CN | claimed |
| CN-114805289-A | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2022-07-29 | — | — | CN | claimed |
| US-20210380508-A1 | SELF-CONDENSATION OF ALDEHYDES | EASTMAN CHEMICAL COMPANY (US) | 2021-12-09 | — | — | US | claimed |
| CN-108884005-B | Synthesis of 2 '-fluoro-6' -methylene-carbocyclic adenosine (FMCA) and 2 '-fluoro-6' -methylene-carbocyclic guanosine (FMCG) | 佐治亚大学研究基金会 | 2021-11-12 | — | — | CN | claimed |
| EP-3880640-A1 | SELF-CONDENSATION OF ALDEHYDES | Eastman Chemical Company (US) | 2021-09-22 | — | — | EP | claimed |
| CN-112970769-A | Application of sesquiterpenoids derivatives in preparation of medicine for preventing and treating wheat scab | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2021-06-18 | — | — | CN | claimed |
| CN-112955423-A | Self-condensation of aldehydes | 伊士曼化工公司 | 2021-06-11 | — | — | CN | claimed |
| EP-3789374-A2 | SYNTHESIS OF 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC ADENOSINE (FMCA) AND 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC GUANOSINE (FMCG) | University of Georgia Research Foundation, Inc. (US) | 2021-03-10 | — | — | EP | claimed |
| EP-3684749-A1 | CATALYTIC CYCLE FOR PRODUCTION OF 1,1-DISUBSTITUTED ALKENES | Sirrus, Inc. (US) | 2020-07-29 | — | — | EP | claimed |
| US-20200223779-A1 | CATALYTIC CYCLE FOR PRODUCTION OF 1,1-DISUBSTITUTED ALKENES | SIRRUS, INC. | 2020-07-16 | — | — | US | claimed |
| US-20200207770-A1 | Synthesis of 2'-Fluoro-6'-Methylene-Carbocyclic Adenosine (FMCA) and 2'-Fluoro-6'Methylene-Carbocyclic Guanosine (FMCG) | UNIV GEORGIA (US) | 2020-07-02 | — | — | US | claimed |
| WO-2020101902-A1 | SELF-CONDENSATION OF ALDEHYDES | EASTMAN CHEMICAL COMPANY (US) | 2020-05-22 | — | — | WO | claimed |
| CN-111165504-A | Application of sesquiterpenoids and derivatives thereof in preparation of medicines for preventing and treating wheat scab | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2020-05-19 | — | — | CN | claimed |
| CN-111108087-A | Catalytic recycle for production of 1, 1-disubstituted olefins | 赛鲁斯股份有限公司 | 2020-05-05 | — | — | CN | claimed |
| US-20190100523-A1 | SYNTHESIS OF 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC ADENOSINE (FMCA) AND 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC GUANOSINE (FMCG) | UNIV OF GEORGIA RESEARCH FOUNDATION IONC (US) | 2019-04-04 | — | — | US | claimed |
| WO-2019060188-A1 | CATALYTIC CYCLE FOR PRODUCTION OF 1,1-DISUBSTITUTED ALKENES | SIRRUS, INC. (US) | 2019-03-28 | — | — | WO | claimed |
| US-12637430-B2 | Interleukin-17 (IL-17) inhibitors | HITGEN INC. (CN) | 2026-05-26 | — | — | US | disclosed |
| US-20260055109-A1 | IBOGAINE COMPOUNDS FOR TREATING BRAIN DISORDERS | UNIV CALIFORNIA (US) | 2026-02-26 | — | — | US | disclosed |
| EP-3656756-B1 | PROCESS FOR THE DIRECT ALPHA-METHYLENATION OF KETONES | SPECIALTY OPERATIONS FRANCE (FR) | 2025-12-03 | — | — | EP | disclosed |
| EP-4177249-B1 | IMMUNOMODULATOR | HITGEN INC (CN) | 2025-12-03 | — | — | EP | disclosed |
| WO-2025096584-A1 | STING AGONISTS, COMPOSITIONS, AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-119504679-A | Chromanone compound and application thereof in preventing and treating kiwi fruit bacterial canker | 安徽农业大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-119350150-A | 4-Butoxyphenyl propenone and preparation method and application thereof | 北京茗泽中和药物研究有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-113166027-B | Direct alpha-methylation of ketones | 罗地亚经营管理公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-114805289-B | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2024-05-28 | — | — | CN | disclosed |
| CN-112055580-B | Method for preparing microcapsules | 弗门尼舍有限公司 | 2024-01-09 | — | — | CN | disclosed |
| US-11851392-B2 | Self-condensation of aldehydes | EASTMAN CHEMICAL COMPANY (US) | 2023-12-26 | — | — | US | disclosed |
| CN-113880766-B | Immunomodulator | 成都先导药物开发股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-113880767-B | Immunomodulator | 成都先导药物开发股份有限公司 | 2023-10-13 | — | — | CN | disclosed |
| US-20230227437-A1 | IMMUNOMODULATOR | HITGEN INC (CN) | 2023-07-20 | — | — | US | disclosed |
| US-20230159465-A1 | IMMUNOMODULATOR | HITGEN INC. (CN) | 2023-05-25 | — | — | US | disclosed |
| EP-4183783-A1 | IMMUNOMODULATOR | Hitgen Inc. (CN) | 2023-05-24 | — | — | EP | disclosed |
| EP-4177249-A1 | IMMUNOMODULATOR | Hitgen Inc. (CN) | 2023-05-10 | — | — | EP | disclosed |
| CN-115974664-A | Synthesis method of 5-chloro-1-indanone | 合肥工业大学 | 2023-04-18 | — | — | CN | disclosed |
| CN-113683598-B | Immunomodulator | 成都先导药物开发股份有限公司 | 2022-10-14 | — | — | CN | disclosed |
| US-11401228-B2 | Process for the direct alpha-methylenation of ketones | RHODIA OPERATIONS (FR) | 2022-08-02 | — | — | US | disclosed |
| CN-114805289-A | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2022-07-29 | — | — | CN | disclosed |
| EP-3510025-B1 | HETEROARYL INHIBITORS OF PAD4 | PADLOCK THERAPEUTICS INC (US) | 2022-06-29 | — | — | EP | disclosed |
| CN-110248934-B | Heteroaryl PAD4 inhibitors | 帕德罗科治疗公司 | 2022-05-24 | — | — | CN | disclosed |
| EP-3758668-B1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH & CIE (CH) | 2022-02-23 | — | — | EP | disclosed |
| US-20220002221-A1 | PROCESS FOR THE DIRECT ALPHA-METHYLENATION OF KETONES | SPECIALTY OPERATIONS FRANCE (FR) | 2022-01-06 | — | — | US | disclosed |
| CN-113880766-A | Immunomodulator | 成都先导药物开发股份有限公司 | 2022-01-04 | — | — | CN | disclosed |
| CN-113880767-A | Immunomodulator | 成都先导药物开发股份有限公司 | 2022-01-04 | — | — | CN | disclosed |
| US-20210380508-A1 | SELF-CONDENSATION OF ALDEHYDES | EASTMAN CHEMICAL COMPANY (US) | 2021-12-09 | — | — | US | disclosed |
| CN-112970769-B | Application of sesquiterpenoids derivatives in preparation of medicine for preventing and treating wheat scab | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2021-11-23 | — | — | CN | disclosed |
| CN-113683598-A | Immunomodulator | 成都先导药物开发股份有限公司 | 2021-11-23 | — | — | CN | disclosed |
| CN-108884005-B | Synthesis of 2 '-fluoro-6' -methylene-carbocyclic adenosine (FMCA) and 2 '-fluoro-6' -methylene-carbocyclic guanosine (FMCG) | 佐治亚大学研究基金会 | 2021-11-12 | — | — | CN | disclosed |
| US-20210299115-A1 | HETEROARYL INHIBITORS OF PAD4 | PADLOCK THERAPEUTICS INC (US) | 2021-09-30 | — | — | US | disclosed |
| EP-3880640-A1 | SELF-CONDENSATION OF ALDEHYDES | Eastman Chemical Company (US) | 2021-09-22 | — | — | EP | disclosed |
| CN-113272315-A | Steroid compounds and application thereof | 张家口华健致远生物科技有限公司 | 2021-08-17 | — | — | CN | disclosed |
| US-20210230178-A1 | TRIOXACARCIN ANALOGS AND DIMERS AS POTENT ANTICANCER AGENTS | WILLIAM MARSH RICE UNIVERSITY (US) | 2021-07-29 | — | — | US | disclosed |
| CN-113166027-A | Direct alpha-methylenation of ketones | 罗地亚经营管理公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-112970769-A | Application of sesquiterpenoids derivatives in preparation of medicine for preventing and treating wheat scab | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2021-06-18 | — | — | CN | disclosed |
| CN-112955423-A | Self-condensation of aldehydes | 伊士曼化工公司 | 2021-06-11 | — | — | CN | disclosed |
| US-11026937-B2 | Heteroaryl inhibitors of PAD4 | PADLOCK THERAPEUTICS, INC. (US) | 2021-06-08 | — | — | US | disclosed |
| US-20210129104-A1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH SA (CH) | 2021-05-06 | — | — | US | disclosed |
| US-10995093-B2 | Synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA) and 2′-fluoro-6′methylene-carbocyclic guanosine (FMCG) | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2021-05-04 | — | — | US | disclosed |
| CN-111165504-B | Application of sesquiterpenoids and derivatives thereof in preparation of medicines for preventing and treating wheat scab | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2021-04-20 | — | — | CN | disclosed |
| EP-3789374-A2 | SYNTHESIS OF 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC ADENOSINE (FMCA) AND 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC GUANOSINE (FMCG) | University of Georgia Research Foundation, Inc. (US) | 2021-03-10 | — | — | EP | disclosed |
| EP-3758668-A1 | PROCESS FOR PREPARING MICROCAPSULES | Firmenich SA (CH) | 2021-01-06 | — | — | EP | disclosed |
| CN-112055580-A | Method for preparing microcapsules | 弗门尼舍有限公司 | 2020-12-08 | — | — | CN | disclosed |
| EP-3440041-B1 | SYNTHESIS OF 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC ADENOSINE (FMCA) AND 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC GUANOSINE (FMCG) | UNIV GEORGIA (US) | 2020-11-18 | — | — | EP | disclosed |
| US-10744213-B2 | Fluorescent compounds for imaging of blood vessels and blood flow, and an in vivo screen for pro- and anti-angiogenic agents | COLOSSUS BIOPHARMA CONSULTANTS COMPANY, LIMITED (TW) | 2020-08-18 | — | — | US | disclosed |
| EP-3684749-A1 | CATALYTIC CYCLE FOR PRODUCTION OF 1,1-DISUBSTITUTED ALKENES | Sirrus, Inc. (US) | 2020-07-29 | — | — | EP | disclosed |
| US-20200223779-A1 | CATALYTIC CYCLE FOR PRODUCTION OF 1,1-DISUBSTITUTED ALKENES | SIRRUS, INC. | 2020-07-16 | — | — | US | disclosed |
| US-20200207770-A1 | Synthesis of 2'-Fluoro-6'-Methylene-Carbocyclic Adenosine (FMCA) and 2'-Fluoro-6'Methylene-Carbocyclic Guanosine (FMCG) | UNIV GEORGIA (US) | 2020-07-02 | — | — | US | disclosed |
| EP-3656756-A1 | PROCESS FOR THE DIRECT ALPHA-METHYLENATION OF KETONES | RHODIA OPERATIONS (FR) | 2020-05-27 | — | — | EP | disclosed |
| WO-2020101902-A1 | SELF-CONDENSATION OF ALDEHYDES | EASTMAN CHEMICAL COMPANY (US) | 2020-05-22 | — | — | WO | disclosed |
| CN-111165504-A | Application of sesquiterpenoids and derivatives thereof in preparation of medicines for preventing and treating wheat scab | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2020-05-19 | — | — | CN | disclosed |
| CN-111108087-A | Catalytic recycle for production of 1, 1-disubstituted olefins | 赛鲁斯股份有限公司 | 2020-05-05 | — | — | CN | disclosed |
| WO-2020030925-A1 | HETEROCYCLIC SUBSTITUTED UREAS, FOR USE AGAINST CANCER | ARTIOS PHARMA LIMITED (GB) | 2020-02-13 | — | — | WO | disclosed |
| WO-2020020829-A1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH SA (CH) | 2020-01-30 | — | — | WO | disclosed |
| CN-110248934-A | Heteroaryl PAD4 inhibitor | 帕德罗科治疗公司 | 2019-09-17 | — | — | CN | disclosed |
| EP-3510025-A1 | HETEROARYL INHIBITORS OF PAD4 | Padlock Therapeutics, Inc. (US) | 2019-07-17 | — | — | EP | disclosed |
| US-20190100523-A1 | SYNTHESIS OF 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC ADENOSINE (FMCA) AND 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC GUANOSINE (FMCG) | UNIV OF GEORGIA RESEARCH FOUNDATION IONC (US) | 2019-04-04 | — | — | US | disclosed |
| WO-2019060188-A1 | CATALYTIC CYCLE FOR PRODUCTION OF 1,1-DISUBSTITUTED ALKENES | SIRRUS, INC. (US) | 2019-03-28 | — | — | WO | disclosed |
| WO-2019036537-A1 | TRIOXACARCIN ANALOGS AND DIMERS AS POTENT ANTICANCER AGENTS | WILLIAM MARSH RICE UNIVERSITY (US) | 2019-02-21 | — | — | WO | disclosed |
| CN-108884005-A | Synthesis of 2 '-fluoro-6' -methylene-carbocyclic adenosine (FMCA) and 2 '-fluoro-6' -methylene-carbocyclic guanosine (FMCG) | 佐治亚大学研究基金会 | 2018-11-23 | — | — | CN | disclosed |
| WO-2018049296-A1 | HETEROARYL INHIBITORS OF PAD4 | PADLOCK THERAPEUTICS, INC. (US) | 2018-03-15 | — | — | WO | disclosed |
| US-9765091-B2 | Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors | ADDEX PHARMA S.A. (CH) | 2017-09-19 | — | — | US | disclosed |
| EP-3166923-A1 | PROCESS FOR PREPARING SUBSTITUTED PHENYLALKANES | Mallinckrodt LLC (US) | 2017-05-17 | — | — | EP | disclosed |
| US-9556108-B2 | Process for preparing substituted phenylalkanes | MALLINCKRODT LLC (US) | 2017-01-31 | — | — | US | disclosed |
| EP-2864308-B1 | (3aR,6aS)-2-Hydroxy-3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-5-carbaldehyde intermediates for the preparation of prostaglandins or prostaglandin analogues | UNIV BRISTOL (GB) | 2016-10-19 | — | — | EP | disclosed |
| EP-2592932-B1 | NOVEL TETRAHYDROPYRAZOLO[3,4-B]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | ADDEX PHARMA SA (CH) | 2016-01-20 | — | — | EP | disclosed |
| US-20160009635-A1 | PROCESS FOR PREPARING SUBSTITUTED PHENYLALKANES | MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY | 2016-01-14 | — | — | US | disclosed |
| WO-2016007823-A1 | PROCESS FOR PREPARING SUBSTITUTED PHENYLALKANES | MALLINCKRODT LLC (US) | 2016-01-14 | — | — | WO | disclosed |
| US-20130267499-A1 | NOVEL TETRAHYDROPYRAZOLO [3,4-b] AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | ADDEX PHARMA SA (CH) | 2013-10-10 | — | — | US | disclosed |
| EP-2592932-A2 | NOVEL TETRAHYDROPYRAZOLO[3,4-B]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | Addex Pharma SA (CH) | 2013-05-22 | — | — | EP | disclosed |
| WO-2012009001-A2 | NOVEL TETRAHYDROPYRAZOLO[3,4-B]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | ADDEX PHARMA S.A. (CH) | 2012-01-19 | — | — | WO | disclosed |
| US-6361940-B1 | IMMOBILIZATION; GENETIC ENGINEERING | QIAGEN GENOMICS, INC. | 2002-03-26 | — | — | US | disclosed |
| EP-0952228-A2 | Compositions and methods for enhancing hybridization specificity | Rapigene, Inc. (US) | 1999-10-27 | — | — | EP | disclosed |
| EP-0952228-A2 | Compositions and methods for enhancing hybridization specificity | Rapigene, Inc. (US) | 1999-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (19 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200223779-A1 | CATALYTIC CYCLE FOR PRODUCTION OF 1,1-DISUBSTITUTED ALKENES | ME1, ME3, ME2 | TDP1 1568/4885MLYCD 84/4885CA2 198/4885 |
| US-10744213-B2 | Fluorescent compounds for imaging of blood vessels and blood flow, and an in vivo screen for pro- and anti-angiogenic agents | FLT4, VEGFA, FLT1 | TDP1 3525/4885MLYCD 3242/4885CA2 1802/4885 |
| US-12637430-B2 | Interleukin-17 (IL-17) inhibitors | IL17A, IL2, IL23R | TDP1 4710/4885MLYCD 3143/4885CA2 1862/4885 |
| US-20160009635-A1 | PROCESS FOR PREPARING SUBSTITUTED PHENYLALKANES | CYP2E1, CYP1B1, CYP4B1 | TDP1 517/4885MLYCD 3571/4885CA2 2374/4885 |
| US-20230159465-A1 | IMMUNOMODULATOR | IL2, IL17A, IL2RA | TDP1 4681/4885MLYCD 3568/4885CA2 4528/4885 |
| US-20210129104-A1 | PROCESS FOR PREPARING MICROCAPSULES | C5, CAPRIN1, EXOSC9 | TDP1 3671/4885MLYCD 476/4885CA2 4616/4885 |
| US-20230227437-A1 | IMMUNOMODULATOR | IL17A, IL2, IL2RA | TDP1 4711/4885MLYCD 2670/4885CA2 4362/4885 |
| US-20200207770-A1 | Synthesis of 2'-Fluoro-6'-Methylene-Carbocyclic Adenosine (FMCA) and 2'-Fluoro-6'Methylene-Carbocyclic Guanosine (FMCG) | RNGTT, NT5C3B, MTAP | TDP1 385/4885MLYCD 1080/4885CA2 2709/4885 |
| US-20210230178-A1 | TRIOXACARCIN ANALOGS AND DIMERS AS POTENT ANTICANCER AGENTS | ANXA5, HCCS, BAX | TDP1 1309/4885MLYCD 2713/4885CA2 2729/4885 |
| US-20130267499-A1 | NOVEL TETRAHYDROPYRAZOLO [3,4-b] AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | GRM4, GRM1, GRIK4 | TDP1 3211/4885MLYCD 2798/4885CA2 2113/4885 |
| US-10995093-B2 | Synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA) and 2′-fluoro-6′methylene-carbocyclic guanosine (FMCG) | RNGTT, NT5C3B, MTAP | TDP1 398/4885MLYCD 1078/4885CA2 2706/4885 |
| US-20210299115-A1 | HETEROARYL INHIBITORS OF PAD4 | PADI4, PADI1, PADI6 | TDP1 22/4885MLYCD 2382/4885CA2 4341/4885 |
| US-11851392-B2 | Self-condensation of aldehydes | ALKBH2, DBF4, ALKBH3 | TDP1 1665/4885MLYCD 1327/4885CA2 352/4885 |
| US-20260055109-A1 | IBOGAINE COMPOUNDS FOR TREATING BRAIN DISORDERS | HTR7, HTR3B, HTR3A | TDP1 1223/4885MLYCD 2984/4885CA2 1842/4885 |
| US-20210380508-A1 | SELF-CONDENSATION OF ALDEHYDES | ALKBH2, DBF4, ALKBH3 | TDP1 1665/4885MLYCD 1327/4885CA2 352/4885 |
| US-11401228-B2 | Process for the direct alpha-methylenation of ketones | ALKBH3, EHMT1, MGMT | TDP1 2476/4885MLYCD 177/4885CA2 1400/4885 |
| US-20190100523-A1 | SYNTHESIS OF 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC ADENOSINE (FMCA) AND 2'-FLUORO-6'-METHYLENE-CARBOCYCLIC GUANOSINE (FMCG) | NT5C3B, RNGTT, MPG | TDP1 433/4885MLYCD 1039/4885CA2 2976/4885 |
| US-11026937-B2 | Heteroaryl inhibitors of PAD4 | PADI4, PADI1, PADI6 | TDP1 22/4885MLYCD 2382/4885CA2 4341/4885 |
| US-20220002221-A1 | PROCESS FOR THE DIRECT ALPHA-METHYLENATION OF KETONES | ALKBH3, EHMT1, MGMT | TDP1 2476/4885MLYCD 177/4885CA2 1400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.